Health at Scale, Corp.

Health at Scale, Corp. specializes in delivering hyper-personalized healthcare solutions to enhance outcomes for patients, employers, and providers, leveraging advanced data analytics for tailored healthcare delivery. Founded in 2015 in San Jose, California, Health at Scale, Corp. focuses on innovative healthcare solutions.

The company's CEO and founder is Zeeshan Syed, who has a background in technology and healthcare improvements. In May 2019, Health at Scale raised USD 16 mn in Series A funding led by Optum, Inc. , which contributed to their single investment round to date, amounting to a total of USD 16 mn. Health at Scale provides a suite of hyper-personalized healthcare solutions designed to optimize outcomes across various stakeholders, including patients, payers, employers, and providers.

Their core offerings include Precision Health™, a comprehensive health benefit that combines targeted outreach with personalized health guidance; Precision Navigation™, which facilitates tailored provider navigation across over 70 specialties and procedures; and Precision Interception™, aimed at proactively predicting and managing rising patient risks to curb healthcare costs. Additionally, Precision Pharmacy™ targets adherence improvement and error reduction; Precision Wellness™ promotes healthier lifestyle choices through community engagement; and Precision FWA Detection™ focuses on identifying fraud, waste, and abuse prior to care authorization. These products primarily serve health plans, employers, third-party administrators (TPAs), brokers, consulting firms, providers, Accountable Care Organizations (ACOs), pharmacies, and pharmacy benefit managers (PBMs) in the United States and select international markets, ensuring that healthcare delivery is personalized and efficient. Health at Scale operates on a B2B transaction model, offering its solutions to businesses and organizations within the healthcare sector.

Their revenue streams derive from subscription-based partnerships, where clients subscribe for access to their technology and services, which include flagship products like Precision Health™ and Precision Pharmacy™. The pricing structure varies based on the specific products and services chosen by clients, with tailored plans designed to meet the unique needs of diverse customer segments. The company's offerings are integrated into the operations of health plans and employers, enabling them to enhance patient care and streamline operations while managing costs. Health at Scale plans to leverage its recent Series A funding of USD 16 mn raised in May 2019 to develop upcoming products and expand its market reach.

The company is currently designing new functionalities within its product suite, with anticipated launches set for late 2023. Additionally, Health at Scale aims to penetrate new geographic markets, specifically targeting opportunities in Europe and Asia within the next two years. The proceeds from the latest funding round will support these initiatives, facilitating product development and market entry strategies.